Takeda Pharmaceutical Company Limited (TAK)

Trade TAK now with
1/5/2021 2:03:50 AM Takeda Completes Sale Of Portfolio Of Select Prescription Products To Cheplapharm For Total Value Of $562 Mln
12/21/2020 2:27:16 AM Takeda Pharma Unveils Sale Of Select Non-Core Assets To Hasten Biopharma For $322 Mln
12/16/2020 9:05:29 AM Prime Therapeutics And Takeda Agree To Outcomes-based Arrangement For Hemophilia A Treatment ADVATE
12/4/2020 9:04:37 AM Y-mAbs, Takeda Announce License, Distribution Agreement For DANYELZA, Omburtamab In Israel
12/4/2020 6:03:07 AM Takeda Says SOLSTICE Trial Met Its Primary Endpoint
12/2/2020 9:03:29 AM Takeda Announces Launch Of MyPKFiT Software For ADYNOVATE
11/30/2020 6:42:18 PM Takeda Completes Sale Of Select OTC And Non-Core Assets To Celltrion In Asia Pacific
11/27/2020 8:03:52 AM Exelixis: Takeda Receives Approval In Japan For CABOMETYX
11/12/2020 6:32:53 AM Zhongchao And Takeda Pharma Expand Scope Of Cooperation In China
11/9/2020 10:04:06 AM Takeda To Highlight Research Commitment In Bleeding Disorders And Personalized Care
11/5/2020 9:07:12 AM Takeda To Present 22 Company-sponsored Abstracts At American Society Of Hematology Annual Meeting
10/29/2020 2:16:56 AM Takeda Expands COVID-19 Vaccine Supply In Japan Through Partnership With Moderna And Government Of Japan
10/29/2020 2:08:46 AM Takeda H1 Reported EPS 55 Yen; Core EPS 221 Yen